Clinicopathological differences between EGFR mutated and EGFR wild-type lung adenocarcinoma with papillary predominant pattern.
Goto E, Taki T, Nomura K, Miyakami Y, Miyoshi T, Tane K, Samejima J, Aokage K, Nagamine M, Sakashita S, Sakamoto N, Kojima M, Suzuki K, Tsuboi M, Ishii G.
Goto E, et al. Among authors: nomura k.
Lung Cancer. 2024 May 23;192:107830. doi: 10.1016/j.lungcan.2024.107830. Online ahead of print.
Lung Cancer. 2024.
PMID: 38805901